PB
Protego Biopharma, Inc.
SEC filingOther Health Care · San Diego, CA
Amount raised$32.9Msold at filing
Total offering$130.4M$97.5M still open
Investors in the raise18count reported to the SEC
FiledDec 3, 2025first sale Oct 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
TIM J. LOHOFFDirector
EDWARD J. HURWITZDirector
HANK MICHAEL PETRASSIExecutive Officer
JANWILLEM J. NAESENSDirector
SAOUSSEN J. BEN HALIMADirector
LAURA J. BRASSDirector
JEFFERY J. KELLYDirector
Brent J. WarnerExecutive Officer, Director
SHELLEY J. CHUDirector
HELEN J. KIMDirector
Executive officers, directors and promoters as listed on the Form D.